Central Trust CO Novo Cure LTD Transaction History

Central Trust CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$11.13 - $15.78 $200 - $284	18 New	18 $0
Q2 2022 Aug 09, 2022	SELL	$56.6 - $89.9 $5,660 - $8,990	-100 Reduced 83.33%	20 $1,000
Q1 2022 May 03, 2022	BUY	$60.15 - $84.52 $4,812 - $6,761	80 Added 200.0%	120 $9,000
Q4 2021 Feb 08, 2022	SELL	$75.08 - $121.99 $750 - $1,219	-10 Reduced 20.0%	40 $3,000
Q2 2021 Jul 23, 2021	SELL	$130.4 - $225.58 $5,216 - $9,023	-40 Reduced 44.44%	50 $11,000
Q1 2021 Apr 23, 2021	SELL	$124.11 - $190.17 $2,482 - $3,803	-20 Reduced 18.18%	90 $11,000
Q4 2020 Jan 29, 2021	SELL	$112.16 - $174.14 $4,486 - $6,965	-40 Reduced 26.67%	110 $19,000
Q3 2020 Oct 22, 2020	SELL	$58.05 - $111.31 $10,449 - $20,035	-180 Reduced 54.55%	150 $16,000
Q1 2020 Apr 17, 2020	BUY	$57.05 - $95.75 $11,410 - $19,150	200 Added 153.85%	330 $22,000
Q3 2019 Oct 28, 2019	BUY	$61.86 - $97.8 $8,041 - $12,714	130 New	130 $10,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Trust CO with notifications on news.